|
|
||||||||
RESEARCH REPORT |
1 Departments of Biomedical Engineering,
2 Chemical Engineering, and
3 Biologic and Materials Sciences, Room 5213 Dental School, 1011 North University, University of Michigan, Ann Arbor, MI 48109-1078, USA;
* corresponding author, mooneyd{at}umich.edu
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: alginate biomaterials tissue engineering irradiation osteoblasts
| INTRODUCTION |
|---|
|
|
|---|
This study addressed the hypothesis that modifying the degradation rate of polymeric materials utilized to transplant bone-forming cells and to engineer bony tissues will directly control the extent of new bone formation. We tested this hypothesis by transplanting osteoblasts into mice using an alginate hydrogel system. Previous studies have demonstrated that alginate hydrogels are useful for the engineering of bony and cartilaginous tissues (Paige et al., 1995; Diduch et al., 2000). These materials are especially attractive for clinical application, since they can be used to transplant cells in a minimally invasive manner, and alginate has been safely used to deliver proteins and cells to patients (Bent et al., 2001; Bratthall et al., 2001). Further, cell adhesion peptides may be covalently coupled to alginate (Rowley et al., 1999), to control the mechanism of cell adhesion and phenotype in vitro (Alsberg et al., 2001a; Rowley and Mooney, 2002) and bone and cartilage formation in vivo (Alsberg et al., 2001a, 2002).
The molecular weight and structure of alginate polymers provide a readily manipulated means for regulation of the degradation rate of hydrogels formed from these polysaccharides. Alginate is comprised of mannuronic (M) and guluronic (G) sugars organized into blocks of M-residues, blocks of G-residues, and blocks comprised of alternating residues, and will form space-filling hydrogels by ionic cross-linking with divalent cations such as calcium. Only the G-blocks participate in ionic cross-linking, and a minimum number of G-residues/block is necessary for cross-linking (Smidsrod and Skjak-Braek, 1990). Main chain scission of alginate at a neutral pH is minimal (Lansdown and Payne, 1994; Draget et al., 1997). Instead, these gels dissolve slowly upon losing divalent cations (Bouhadir et al., 2001b). We hypothesized that the molecular weight of alginate will regulate chelation of the cross-linking calcium and gel dissolution in vivo. In this study, alginate has been irradiated to control these features and test their role in bone tissue engineering.
| MATERIALS & METHODS |
|---|
|
|
|---|
-MEM and 100 units/mL PS (Gibco BRL, Gaithersburg, MD, USA), yielding 2% and 3% w/w solutions, and were sterile-filtered through a 0.22-µm syringe filter. The number of G-residues/G-block and the G-content were determined as previously described (Kong et al., 2002). Gel disks (6 mm diameter, 2 mm thick) were formed as previously described (Rowley et al., 1999) from (1) 0 Mrad 2% alginate, (2) 5 Mrad 2% alginate, and (3) 8 Mrad 3% alginate, and were implanted subcutaneously into the backs of 4- to 5-week-old anesthetized male CB-17 SCID mice (Taconic Farms, Inc., Germantown, NY, USA). Disks were harvested and weighed at 2, 4, and 12 wks. The elastic moduli were measured (Kong et al., 2002), and samples that could not be positively identified were assumed to have negligible mass and negligible elastic moduli. Statistical analysis of the mass and elastic moduli data was performed by unpaired one-tailed Students t tests unless the difference between standard deviations was determined to be significant, in which case the one-tailed alternate Welsh t test was performed. Statistical significance was defined by P < 0.05.
Implantation of Osteoblasts into Peptide Modified Alginates
G4RGDSP peptides (Commonwealth Biotechnologies, Inc., Richmond, VA, USA) were covalently coupled to the alginates (Rowley et al., 1999) to achieve a peptide density of 1.5 x 105 nmol/L when alginates were reconstituted to a 2% w/w solution in
-MEM. This peptide type and density significantly increase the amount of in vivo bone formed compared with unmodified alginate (Alsberg et al., 2001a). Primary rat-derived calvarial osteoblasts (PRCO) were isolated (Pockwinse et al., 1992) from 1- to 3-day-old newborn Lewis rats (Harlan Sprague Dawley, Inc., Indianapolis, IN, USA) and mixed at a concentration of 24.5 x 106 cells/mL with (1) non-irradiated alginate-G4RGDSP and (2) 8-Mrad-treated alginate-G4RGDSP. Cell-alginate constructs were cross-linked with calcium sulfate, and 200 µL per implant was injected into the backs of 4- to 5-week-old anesthetized male CB-17 SCID mice as previously described (Alsberg et al., 2001a).
Implants were harvested at 6 (N = 5), 13 (N = 5), and 21 (N = 5) wks, weighed, imaged on a DEXA scanner for determination of bone mineral density (BMD) and bone mineral content (BMC), and subjected to constant strain rate compression tests at 21 wks (N = 4). Samples were assayed for calcium (Calcium Kit, Sigma, St. Louis, MO, USA), phosphate (Heinonen and Lahti, 1981), and DNA content (Schneider, 1957). The 6- and 13-week specimens were paraffin-embedded, sectioned, and stained with hematoxylin and eosin (H/E), and the 21-week specimens were plastic-embedded (Pathology Associates, West Chester, OH, USA), sectioned, and stained with Goldners Trichrome. Histomorphometric analysis was performed for quantitative determination of bone fraction as previously described (Alsberg et al., 2002). Specimens at 21 wks were imaged at a resolution of 9 µm by means of a three-dimensional microcomputed tomography (µCT) system and reconstructed at a resolution of 18 µm for qualitative examination of the microarchitecture of the engineered bone tissue. Statistical comparison of bone formation in the alginate delivery vehicles was performed by paired one-tailed Students t tests, and statistical significance was defined by P < 0.05. A protocol based on NIH guidelines for the care and use of laboratory animals (NIH Publication #85-23 Rev 1985) was reviewed and approved by an institutional review board and was observed in all procedures.
| RESULTS |
|---|
|
|
|---|
|
Bone Formation
The ability of alginate hydrogels of various degradation rates to allow bony tissue to form from primary rat calvarial osteoblasts (PRCO) was next tested with the use of non-irradiated alginate and alginate irradiated with 8 Mrad. More rapidly degrading gels allowed for improved bone formation, since these samples grossly demonstrated the presence of a mineralized, vascularized tissue which was stiffer than the non-irradiated samples. Histological examination of the non-irradiated alginate implants revealed strips of bone tissue that grew in size over time, but large islands of residual alginate remained at all times (Figs. 2A, 2C, 2E
). In contrast, the irradiated specimens were comprised of many small islands of residual alginate surrounded by new tissue (Fig. 2B
), and the residual alginate islands decreased in size and the bony trabeculae grew thicker and more interconnected over time (Figs. 2D, 2F
). The non-irradiated alginate condition maintained its mass throughout the duration of the study (Fig. 3A
). In contrast, the irradiated specimens decreased their mass by almost 50% after 6 wks and then gradually increased in mass to a value statistically similar to that of the control at 21 wks. The initial decrease may be attributable to alginate degradation, and the subsequent increase to new bone formation. DEXA imaging revealed that the BMC significantly increased over time in the irradiated alginate group and increased modestly in the non-irradiated control (Fig. 3B
). BMD significantly increased over time in both groups, but was significantly greater in the irradiated group than in the non-irradiated control at 21 wks (Fig. 3C
). Chemical assays demonstrated that phosphate and calcium content significantly increased over time in both experimental groups, but there was significantly more phosphate and calcium content in the irradiated alginate condition compared with the non-irradiated control at 13 wks (data not shown). Hydroxyapatite (Ca10(PO4)6(OH)2), the mineralized portion of native bone, has a calcium-to-phosphate molar ratio of 1.67, and a similar ratio was found in both experimental groups at 13 and 21 wks. Histomorphometric analysis confirmed that the increases in mineral content were a direct result of increased bone tissue formation, and at all time points, significantly more bony tissue was formed in the irradiated alginate group compared with the non-irradiated control (Fig. 3D
).
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Hydrogels composed of high-molecular-weight alginate exhibit limited biodegradation (Lansdown and Payne, 1994; Shapiro and Cohen, 1997), likely as a result of slow exchange of divalent cation cross-linkers with monovalent cations present in the environment surrounding the hydrogels. Several techniques have been reported to reduce the molecular weight of alginate, including radiation (Kume and Takehisa, 1983; Nagasawa et al., 2000), acid (Haug et al., 1966; Bouhadir et al., 2000), and enzyme treatment (Tsujino and Saito, 1961; Nakada and Sweeny, 1967; Shimokawa et al., 1996), and oxidation of alginate also regulates its biodegradation (Bouhadir et al., 2001b). Gamma-irradiation was utilized in these studies because it is a simple, readily controlled method that is unlikely to result in harmful by-products. The application of 8 Mrad or less of radiation treatment preferentially causes chain scission within MG-blocks (Kong et al., 2002), and the lengths of individual GG-blocks are unaltered. The radiation dose of 8 Mrad was chosen for cell transplantation experiments because it yielded a polymer molecular weight low enough to allow for ultimate renal clearance (Al-Shamkhani and Duncan, 1995), while still forming initially stable gels that rapidly degraded in vivo. The concentration of this alginate in the gels was varied between 2 and 3%, but this appeared to have little effect on the degradation rate (data not shown). A constant alginate concentration (2%) was utilized for the cell transplantation study, to be consistent with previous studies (Alsberg et al., 2001a, 2002).
This study illustrates that a polymer scaffolds ability to degrade in concert with new tissue formation is a critical tissue engineering matrix parameter that allows for more rapid tissue formation and replacement with the desired tissue type. Control of both the degradation and adhesion characteristics of a polymer scaffold will be a powerful tool in regulating the regeneration processes of a broad range of tissues. The appropriate biomaterial degradation rate required for a specific tissue will likely be a function of the metabolic activity of the cell type(s) used for transplantation and the specific strategy for defect repair.
| ACKNOWLEDGMENTS |
|---|
Received March 27, 2003; Last revision July 30, 2003; Accepted August 4, 2003
| REFERENCES |
|---|
|
|
|---|
Alsberg E, Anderson KW, Albeiruti A, Franceschi RT, Mooney DJ (2001a). Cell interactive alginate hydrogels for bone tissue engineering. J Dent Res 80:20252029.
Alsberg E, Hill EE, Mooney DJ (2001b). Craniofacial tissue engineering. Crit Rev Oral Biol Med 12:6475.[Abstract]
Alsberg E, Anderson KW, Albeiruti A, Rowley JA, Mooney DJ (2002). Engineering growing tissues. Proc Natl Acad Sci USA 99:1202512030.
Bent AE, Tutrone RT, McLennan MT, Lloyd LK, Kennelly MJ, Badlani G (2001). Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol Urodyn 20:157165.[ISI][Medline]
Bouhadir KH, Kruger GM, Lee KY, Mooney DJ (2000). Sustained and controlled release of daunomycin from cross-linked poly(aldehyde guluronate) hydrogels. J Pharm Sci 89:910919.[ISI][Medline]
Bouhadir KH, Alsberg E, Mooney DJ (2001a). Hydrogels for combination delivery of antineoplastic agents. Biomaterials 22:26252633.[ISI][Medline]
Bouhadir KH, Lee KY, Alsberg E, Damm KL, Anderson KW, Mooney DJ (2001b). Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog 17:945950.[Medline]
Bratthall G, Lindberg P, Havemose-Poulsen A, Holmstrup P, Bay L, Söderholm G, et al. (2001). Comparison of ready-to-use EMDOGAIN-gel and EMDOGAIN in patients with chronic adult periodontitis. J Clin Periodontol 28:923929.[ISI][Medline]
Bryant SJ, Anseth KS (2002). Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed Mater Res 59:6372.[ISI][Medline]
Diduch DR, Jordan LC, Mierisch CM, Balian G (2000). Marrow stromal cells embedded in alginate for repair of osteochondral defects. Arthroscopy 16:571577.[ISI][Medline]
Draget KI, Skjak-Braek G, Smidsrod O (1997). Alginate based new materials. Int J Biol Macromol 21:4755.[ISI][Medline]
Haug A, Larsen B, Smidsrod O (1966). A study of the constitution of alginic acid by partial acid hydrolysis. Acta Chem Scand 20:183190.
Heinonen JK, Lahti RJ (1981). A new and convenient colorimetric determination of inorganic orthophosphate and its application to the assay of inorganic pyrophosphatase. Anal Biochem 113:313317.[ISI][Medline]
Kong H-J, Lee KY, Mooney DJ (2002). Decoupling the dependence of rheological/mechanical properties of hydrogels from solids concentration. Polymer 43:62396246.
Kume T, Takehisa M (1983). Effects of gamma-irradiation on sodium alginate and carrageenan powder. Agric Biol Chem 47:889890.
Lansdown AB, Payne MJ (1994). An evaluation of the local reaction and biodegradation of calcium sodium alginate (Kaltostat) following subcutaneous implantation in the rat. J R Coll Surg Edinb 39:284288.[Medline]
Nagasawa N, Mitomo H, Yoshii F, Tamikazu K (2000). Radiation-induced degradation of sodium alginate. Polym Degr Stabil 69:279285.
Nakada HI, Sweeny PC (1967). Alginic acid degradation by eliminases from abalone hepatopancreas. J Biol Chem 242:845851.
Nerem RM, Sambanis A (1995). Tissue engineering: from biology to biological substitutes. Tissue Eng 1:313.
Paige KT, Cima LG, Yaremchuk MJ, Vacanti JP, Vacanti CA (1995). Injectable cartilage. Plast Reconstr Surg 96:13901398.[ISI][Medline]
Pockwinse SM, Wilming LG, Conlon DM, Stein GS, Lian JB (1992). Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures. J Cell Biochem 49:310323.[ISI][Medline]
Pollok JM, Vacanti JP (1996). Tissue engineering. Semin Pediatr Surg 5:191196.[Medline]
Putnam AJ, Mooney DJ (1996). Tissue engineering using synthetic extracellular matrices. Nat Med 2:824826.[ISI][Medline]
Rowley JA, Mooney DJ (2002). Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res 60:217223.[ISI][Medline]
Rowley JA, Madlambayan G, Mooney DJ (1999). Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20:4553.[ISI][Medline]
Schneider WC (1957). Determination of nucleic acids in tissues by pentose analysis. Methods Enzymol 3:680684.[ISI]
Shapiro L, Cohen S (1997). Novel alginate sponges for cell culture and transplantation. Biomaterials 18:583590.[ISI][Medline]
Shimokawa T, Yoshida S, Takeuchi T, Murata K, Ishii T, Kushakabe A (1996). Preparation of two series of oligoguluronic acids from sodium alginate by acid hydrolysis and enzymatic degradation. Biosci Biotechnol Biochem 60:15321534.
Smidsrod O, Skjak-Braek G (1990). Alginate as immobilization matrix for cells. Trends Biotechnol 8:7178.[ISI][Medline]
Tsujino I, Saito T (1961). A new unsaturated uronide isolated from alginase hydrolyse. Nature 192:970971.[Medline]
Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG (1996). Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 17:175185.[ISI][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |